U.S. Insurance Stock News

Stock performance snapshot and recent context Cullen/Frost Bankers (CFR) has attracted fresh attention from investors after recent share price moves, with the stock showing positive returns over the past week, month, past 3 months, and year to date. Over the past week the stock returned 5.9%, with gains of 5.1% over the past month and 8.3% over the past 3 months. Year to date, the total return stands at 5.9%, while the 1 year total return is 5.6%. See our latest analysis for Cullen/Frost...

Potential Dorian LPG Ltd. ( NYSE:LPG ) shareholders may wish to note that the Chairman of the Board, John Hadjipateras...

In recent days, First American Financial reported higher quarterly revenue and net profit than the prior year, while Barclays’ Terry Ma reaffirmed a Hold rating and analysts maintained a Moderately Buy-leaning consensus view. This combination of improving financial performance and broadly constructive analyst sentiment may be reshaping how investors assess the company’s earnings profile and resilience. Next, we’ll examine how the stronger quarterly results could influence First American...

Recently, Paymentus Holdings reported that it continues to upgrade its cloud-based billing and payment platform and deepen integrations across utilities, municipalities, healthcare, and government, while management reaffirmed its full-year outlook for steady growth and improving margins. An interesting angle is how these enhancements in essential recurring payment flows may strengthen Paymentus’ role as infrastructure-like software for billers across multiple regulated sectors. Next, we’ll...

In recent days, O’Reilly Automotive’s past five-year performance and its upcoming fiscal Q4 2025 earnings announcement have drawn attention, as analysts anticipate improved earnings following stronger-than-expected Q3 2025 results and a raised full-year revenue outlook driven by solid demand for replacement auto parts. The company’s historical compounding of returns and analysts’ continued strong buy consensus highlight how consistent execution in the auto parts market can materially...

Pomerantz LLP recently announced it is investigating potential claims on behalf of investors of Village Farms International, Inc., inviting affected shareholders to contact the firm for more information. This type of investor-focused legal review can intensify scrutiny of Village Farms’ governance and disclosures, adding a new layer of risk perception around the company. We’ll now examine how this investor legal investigation could influence Village Farms International’s cannabis-focused...

In recent updates, Celldex Therapeutics reported progression of its antibody pipeline, including global Phase 3 trials for barzolvolimab in chronic urticarias and early-stage data for bispecific antibody CDX-622. A key insight for investors is Celldex’s cash runway reportedly extending through 2027, supporting continued development of these late- and mid-stage programs. Next, we’ll explore how this pipeline momentum, particularly the Phase 3 barzolvolimab program, shapes Celldex...

Why the latest earnings report matters for AdaptHealth AdaptHealth (AHCO) recently reported quarterly revenue of US$820.3 million, which came in 2.5% above analyst estimates, with full year guidance aligned to market expectations despite slower growth compared with peers. This mix of modest outperformance and steady guidance has drawn fresh attention to the stock as investors weigh how a slower growing home medical equipment provider fits into a sector facing labor cost and reimbursement...

Over the past year, Inspire Medical Systems has faced multiple class action lawsuits alleging it misled investors about demand, preparedness, and execution for its Inspire V next‑generation sleep apnea device launch, alongside operational rollout issues highlighted by at least one institutional investor exiting its position. These legal challenges and execution concerns sit in sharp contrast to prior enthusiasm about Inspire’s technology, underscoring how operational follow-through and...

If you are wondering whether EVERTEC at around US$30.17 is offering value right now, you are not alone. This article is built to help you weigh what that price might really mean. The stock has returned 5.2% over the last 7 days and 1.5% over the last 30 days, while year to date it is up 5.2%. However, its 1 year, 3 year and 5 year returns of 4.5%, 11.1% and 19.3% declines tell a different story. Recent attention on EVERTEC has been shaped more by its share price history and sector sentiment...

Jack Henry & Associates (JKHY) is back in focus after a cluster of analyst upgrades and a fresh core banking deal with Sanibel Captiva Community Bank, putting its fintech franchise under renewed investor scrutiny. See our latest analysis for Jack Henry & Associates. The recent core banking win with Sanibel Captiva Community Bank and a wave of analyst upgrades have coincided with a 24.29% 90 day share price return and an 11.46% 1 year total shareholder return, pointing to momentum that...

Nomad Foods recently outlined a plan to streamline its operations between 2026 and 2028 targeting US$200 million in cost savings, while continuing share repurchases and maintaining a dividend yield of 5.8% supported by current earnings. Insider share purchases at decade-low valuation levels, alongside consistent free cash flow generation and ongoing buybacks that have reduced the share count by about 4% annually since 2021, underline management’s confidence in the business. We’ll now examine...

With a price-to-earnings (or "P/E") ratio of 27.9x Veralto Corporation ( NYSE:VLTO ) may be sending bearish signals at...

Atmus Filtration Technologies Inc. ( NYSE:ATMU ), might not be a large cap stock, but it received a lot of attention...

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

Key Insights The considerable ownership by individual investors in GrabAGun Digital Holdings indicates that they...

Despite an already strong run, GSI Technology, Inc. ( NASDAQ:GSIT ) shares have been powering on, with a gain of 37% in...

While Formula One Group ( NASDAQ:FWON.K ) shareholders are probably generally happy, the stock hasn't had particularly...

You may think that with a price-to-sales (or "P/S") ratio of 1.1x Karyopharm Therapeutics Inc. ( NASDAQ:KPTI ) is...

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

Key Insights The projected fair value for OKYO Pharma is US$4.58 based on 2 Stage Free Cash Flow to Equity Current...

Ultra Clean Holdings, Inc. ( NASDAQ:UCTT ) shares have had a really impressive month, gaining 31% after a shaky period...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

Some stocks are best avoided. We don't wish catastrophic capital loss on anyone. Anyone who held Cryoport, Inc...